Yubo International Biotech Limited
YBGJ
$0.0163
-$0.0097-37.31%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -38.59% | 33.76% | |||
| Depreciation & Amortization | 1.12% | 5.19% | |||
| Other Operating Expenses | -168.56% | 38.69% | |||
| Total Operating Expenses | -46.57% | 32.38% | |||
| Operating Income | 46.57% | -32.38% | |||
| Income Before Tax | 46.57% | -32.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.57% | -32.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -38.80% | -49.84% | |||
| Net Income | 47.13% | -50.36% | |||
| EBIT | 46.57% | -32.38% | |||
| EBITDA | 51.60% | -36.09% | |||
| EPS Basic | 47.22% | -50.00% | |||
| Normalized Basic EPS | 50.00% | -69.23% | |||
| EPS Diluted | 47.22% | -50.00% | |||
| Normalized Diluted EPS | 50.00% | -69.23% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||